In our study, miR-29-x was predicted to target the DETmR AP-1 complex subunit gamma-1 (AP1G1), which in mammals is known to affect HIV-1 infection by influencing the process of HIV-mediated CD4 internalization and targeting to lysosomes [56]. This evidence concerns the gene AP1G1 and HIV-1 infection.